Supporting appropriations for DOT, OSHA, CDC, NIOSH
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of safety positions
Duration: October 1, 2017
to
present
General Issues: Budget/Appropriations , Health Issues , Labor Issues/Antitrust/Workplace , Transportation , Roads/Highway , Alcohol & Drug Abuse , Government Issues
Spending: about $450,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Labor - Dept of (DOL), Occupational Safety & Health Administration (OSHA), Transportation - Dept of (DOT), Health & Human Services - Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Federal Motor Carrier Safety Administration, Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Natl Drug Control Policy (NDCP), White House Office, Federal Highway Administration (FHA), Federal Communications Commission (FCC), Drug Enforcement Administration (DEA), Natl Park Service (NPS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jane Terry
LA to Sen. Max Cleland and Senior Policy Advisor to Rep. Denise Majette
Senator Max Cleland LA and Cong. Denise Majette Policy Advisor
Julie Hrdlicka
Associate Director, Office of the Asst. Secretary for Govt. Affairs, US Department of Transportation; Dem. Staff Asst., Senate Committee on Commerce, Science & Transportation; Staff Asst., Senator Mark Dayton
Julian Hoffman
n/a
Thomas Supinka
n/a
Brian Callahan
n/a
Anthony Abron
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2024
In Q2, National Safety Council had in-house lobbyists. The report was filed on July 1.
Original Filing: 301580942.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
1st Quarter, 2024
In Q1, National Safety Council had in-house lobbyists. The report was filed on June 26.
Original Filing: 301580452.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
4th Quarter, 2023
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301536544.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
3rd Quarter, 2023
In Q3, National Safety Council had in-house lobbyists. The report was filed on Nov. 29, 2023.
Original Filing: 301520038.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of people in key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of people in safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
2nd Quarter, 2023
In Q2, National Safety Council had in-house lobbyists. The report was filed on July 21, 2023.
Original Filing: 301493007.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services and opioid overdose reversal drugs
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of people in key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of people in safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
1st Quarter, 2023
In Q1, National Safety Council had in-house lobbyists. The report was filed on April 24, 2023.
Original Filing: 301468889.xml
Lobbying Issues
Supporting appropriations for DOT, OSHA, CDC, NIOSH
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Access to opioid use disorder (OUD) treatment and services, support for OUD workforce development, support for workplaces to access OUD services
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
support for safe and healthy workplaces and improving data collection around safety incidents in workplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
support implementation of vehicle safety technology
support implementation of Safe System approach
support nomination and confirmation of people in key safety positions at DOT
support efforts to reduce distracted driving, impaired driving and speeding and improve occupant protection
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
support improvements to roadway safety to reduce impaired driving, distracted driving, and speeding, improve occupant protection
support implementation of the Safe System approach
support nominations and confirmations of people in safety positions
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
4th Quarter, 2022
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 19, 2023.
Original Filing: 301435105.xml
Lobbying Issues
FY23 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; measures to address cannabis impairment and safety implications; HR7666 (Restoring Hope for Mental Health and Well-Being Act of 2022)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
OSHA and NIOSH funding in FY23 L-HHS bills, workplace safety measures, Improving Federal Nonprofit Partnerships (HR7587)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Discussion of New Car Assessment Program (NCAP) updates, as well as discussion of efforts to reduce distracted driving, alcohol impairment, and improve highway safety.
S.Res. 321 and H.Res. 565 express Congressional support for a goal of zero road deaths
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
Lobbying Issues
S.Res. 321 and H.Res. 565 express Congressional support for a goal of zero road deaths
Road safety improvements including adoption and implementation of the Safe System approach
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
3rd Quarter, 2022
In Q3, National Safety Council had in-house lobbyists. The report was filed on Oct. 18, 2022.
Original Filing: 301407256.xml
Lobbying Issues
FY23 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; measures to address the increased usage of cannabis; HR7666 (Restoring Hope for Mental Health and Well-Being Act of 2022)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
OSHA and NIOSH funding in FY23 L-HHS bills, workplace safety measures, Improving Federal Nonprofit Partnerships (HR7587)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Discussion of New Car Assessment Program (NCAP) updates, as well as discussion of efforts to reduce distracted driving, alcohol impairment, and improve highway safety.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
2nd Quarter, 2022
In Q2, National Safety Council had in-house lobbyists. The report was filed on Aug. 4, 2022.
Original Filing: 301398177.xml
Lobbying Issues
FY23 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; measures to address the increased usage of cannabis; HR7666 (Restoring Hope for Mental Health and Well-Being Act of 2022)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL)
Lobbying Issues
OSHA and NIOSH funding in FY23 L-HHS bills, workplace safety measures, Improving Federal Nonprofit Partnerships (HR7587)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC) Labor - Dept of (DOL) Occupational Safety & Health Administration (OSHA)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Discussion of New Car Assessment Program (NCAP) updates, as well as discussion of efforts to reduce distracted driving, alcohol impairment, and improve highway safety.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT)
1st Quarter, 2022
In Q1, National Safety Council had in-house lobbyists. The report was filed on April 27, 2022.
Original Filing: 301373667.xml
Lobbying Issues
FY22 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; measures to address the increased usage of cannabis; Marijuana Opportunity Reinvestment and Expungement Act (MORE Act, H.R. 3617)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
OSHA and NIOSH funding in FY23 L-HHS bills, workplace and COVID safety measures
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Discussion of New Car Assessment Program (NCAP) updates, as well as discussion of efforts to reduce distracted driving, alcohol impairment, and improve highway safety.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 21, 2022.
Original Filing: 301339365.xml
Lobbying Issues
FY22 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; measures to address the opioid overdose epidemic, Comprehensive Addiction Resources Emergency (CARE) Act of 2021 (S. 3218, H.R. 6311)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
OSHA and NIOSH funding in FY23 L-HHS bills, workplace and COVID safety measures
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Infrastructure Investment and Jobs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, National Safety Council had in-house lobbyists. The report was filed on Oct. 25, 2021.
Original Filing: 301316184.xml
Lobbying Issues
FY22 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; support for the MAT Act (H.R.1384/S.445), MATE Act (H.R.2067), and Medicaid Reentry Act (H.R.955)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
OSHA and NIOSH funding in FY22 L-HHS bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Transportation Equity; Impaired Driving; Support for NHTSA Section 405 funding; complete streets projects; Support for the SAFE TO DRIVE Act (H.R.762/S.195); INVEST in America Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, National Safety Council had in-house lobbyists. The report was filed on Aug. 3, 2021.
Original Filing: 301293520.xml
Lobbying Issues
FY22 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; support for the MAT Act (H.R.1384/S.445), MATE Act (H.R.2067), and Medicaid Reentry Act (H.R.955)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
OSHA and NIOSH funding in FY22 L-HHS bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Transportation Equity; Impaired Driving; Support for NHTSA Section 405 funding; complete streets projects; Support for the SAFE TO DRIVE Act (H.R.762/S.195); INVEST in America Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, National Safety Council had in-house lobbyists. The report was filed on April 21, 2021.
Original Filing: 301268400.xml
Lobbying Issues
FY22 appropriations for CDC, OSHA, DOL, DOT (FMCSA, NHTSA, FHWA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Substance use disorder prevention and treatment, mental health, telehealth access; support for the MAT Act (H.R.1384/S.445), MATE Act (H.R.2067), and Medicaid Reentry Act (H.R.955)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
worker protection and safety
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Transportation Equity; Impaired Driving; Support for NHTSA Section 405 funding; complete streets projects; Support for the SAFE TO DRIVE Act (H.R.762/S.195)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 25, 2021.
Original Filing: 301246609.xml
Lobbying Issues
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention; efforts to address the COVID-19 pandemic
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; surface transportation reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration
3rd Quarter, 2020
In Q3, National Safety Council had in-house lobbyists. The report was filed on Oct. 21, 2020.
Original Filing: 301224789.xml
Lobbying Issues
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
2nd Quarter, 2020
National Safety Council amended a lobbying report for in-house lobbying in Q22020 on Oct. 16, 2020
Original Filing: 301211873.xml
Lobbying Issues
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
2nd Quarter, 2020
In Q2, National Safety Council had in-house lobbyists. The report was filed on July 30, 2020.
Original Filing: 301204275.xml
Lobbying Issues
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills, CARES Act, Families First Coronavirus Response Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
continued efforts to address the opioid epidemic; older adult falls; workplace safety concerns due to COVID-19; access to COVID-19 testing for businesses; general injury prevention; CARES Act, Families First Coronavirus Response Act; mental health issues; de-scheduling of cannabis
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls; OSHA emergency temporary standard on COVID-19; general workplace safety issues related to COVID-19
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; Federal Motor Vehicle Safety Standards (FMVSS); advanced driver-assistance systems (ADAS); school bus safety; 5.9GHz safety spectrum; automated enforcement in work zones; INVEST in America Act; Moving America Forward Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA) Federal Communications Commission (FCC)
Lobbying Issues
de-scheduling of cannabis
Agencies Lobbied
U.S. House of Representatives U.S. Senate Drug Enforcement Administration (DEA) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
federal worker safety during coronavirus pandemic
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; Federal Motor Vehicle Safety Standards (FMVSS); advanced driver-assistance systems (ADAS); school bus safety; 5.9GHz safety spectrum; automated enforcement in work zones; INVEST in America Act; Moving America Forward Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA) Natl Highway Traffic Safety Administration (NHTSA)
1st Quarter, 2020
In Q1, National Safety Council had in-house lobbyists. The report was filed on March 31, 2020.
Original Filing: 301153384.xml
Lobbying Issues
FY 21 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
4th Quarter, 2019
In Q4, National Safety Council had in-house lobbyists. The report was filed on Dec. 30, 2019.
Original Filing: 301102775.xml
Lobbying Issues
FY 20 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
3rd Quarter, 2019
National Safety Council amended a lobbying report for in-house lobbying in Q32019 on Oct. 17, 2019
Original Filing: 301067423.xml
Lobbying Issues
FY 20 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs; older adult falls
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
3rd Quarter, 2019
In Q3, National Safety Council had in-house lobbyists. The report was filed on Sept. 30, 2019.
Original Filing: 301062614.xml
Lobbying Issues
FY 20 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
continued efforts to address the opioid epidemic; older adult falls; general injury prevention
HR 3925- Reducing Barriers to Substance Use Treatment Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
Voluntary Protection Programs
Falls Prevention/Workplace Safety/Impairment on the job
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization; school bus safety; kids in hot cars legislation; 18 year old CDL pilot program
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
2nd Quarter, 2019
In Q2, National Safety Council had in-house lobbyists. The report was filed on July 2, 2019.
Original Filing: 301042760.xml
Lobbying Issues
FY 20 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA) Federal Motor Carrier Safety Administration Federal Highway Administration (FHA)
1st Quarter, 2019
In Q1, National Safety Council had in-house lobbyists. The report was filed on April 15, 2019.
Original Filing: 301025341.xml
Lobbying Issues
FY 20 appropriations, specifically in LHHS (ACL, CDC Injury Center, NIOSH, OSHA) and THUD (FHWA, FMCSA, NHTSA) bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations (ACL, CDC Injury Center); continued efforts to address the opioid epidemic; older adult falls; general injury prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) Natl Park Service (NPS) White House Office
Lobbying Issues
OSHA appropriations; NIOSH appropriations; Voluntary Protection Programs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
THUD appropriations, including FHWA, FMCSA and NHTSA; automated vehicles; advanced driver-assistance systems; safe infrastructure; FAST Act reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
4th Quarter, 2018
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 11, 2019.
Original Filing: 301003661.xml
Lobbying Issues
FY 2019 appropriations, specifically pertaining to the LHHS and THUD bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations and their impact on health issues; ongoing legislative efforts to address opioid crisis; HR 5892 - creating an advisory committee inside DOL to assist employers with the opioid epidemic; HR 6 - comprehensive opioid legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) Natl Park Service (NPS) White House Office
Lobbying Issues
OSHA and NIOSH appropriations; general funding for workplace safety issues; HR 5892 - creating an advisory committee inside DOL to assist employers with the opioid epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Funding for FHWA, FMCSA and NHTSA traffic safety priorities; general support for traffic safety issues; S 3432, HR 6773 & HR 2160 - concerning school bus safety; automated vehicle legislation, including S1885 (The American Vision for Safer Transportation Through Advancement of Revolutionary Technologies) and HR3388 (SELF DRIVE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
3rd Quarter, 2018
In Q3, National Safety Council had in-house lobbyists. The report was filed on Oct. 4, 2018.
Original Filing: 300982825.xml
Lobbying Issues
FY 2019 appropriations, specifically pertaining to the LHHS and THUD bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations and their impact on health issues; ongoing legislative efforts to address opioid crisis; HR 5892 - creating an advisory committee inside DOL to assist employers with the opioid epidemic; HR 6 - comprehensive opioid legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) Natl Park Service (NPS) White House Office
Lobbying Issues
OSHA and NIOSH appropriations; general funding for workplace safety issues; HR 5892 - creating an advisory committee inside DOL to assist employers with the opioid epidemic
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Funding for NHTSA traffic safety priorities; general support for traffic safety issues; S 3432, HR 6773 & HR 2160 - concerning school bus safety; automated vehicle legislation, including S1885 (The American Vision for Safer Transportation Through Advancement of Revolutionary Technologies) and HR3388 (SELF DRIVE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
2nd Quarter, 2018
In Q2, National Safety Council had in-house lobbyists. The report was filed on July 16, 2018.
Original Filing: 300965063.xml
Lobbying Issues
FY 2019 appropriations, specifically pertaining to the LHHS and THUD bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations and their impact on health issues; ongoing legislative efforts to address opioid crisis; efforts to bring NSC "Stop Everyday Killers" opioid public education campaign across US; hr 5892 - creating an advisory committee inside HHS to assist employers with the opioid epidemic
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) Natl Park Service (NPS) White House Office
Lobbying Issues
OSHA and NIOSH appropriations; general funding for workplace safety issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Funding for NHTSA traffic safety priorities; general support for traffic safety issues; HR 2160 - providing grants for school bus seat belts; automated vehicle legislation, including S1885 (The American Vision for Safer Transportation Through Advancement of Revolutionary Technologies) and HR3388 (SELF DRIVE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
1st Quarter, 2018
In Q1, National Safety Council had in-house lobbyists. The report was filed on April 12, 2018.
Original Filing: 300944258.xml
Lobbying Issues
FY 2018 & FY 2019 appropriations, specifically pertaining to the LHHS and THUD bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
LHHS appropriations and their impact on health issues; ongoing legislative efforts to address opioid crisis; efforts to bring NSC "Stop Everyday Killers" opioid public education campaign to Washington, DC
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP) Natl Park Service (NPS) White House Office
Lobbying Issues
OSHA and NIOSH appropriations; general funding for workplace safety issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Funding for NHTSA traffic safety priorities; general support for traffic safety issues; automated vehicle legislation, including S1885 (The American Vision for Safer Transportation Through Advancement of Revolutionary Technologies) and HR3388 (SELF DRIVE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
4th Quarter, 2017
In Q4, National Safety Council had in-house lobbyists. The report was filed on Jan. 3, 2018.
Original Filing: 300921190.xml
Lobbying Issues
FY 2018 appropriations, specifically pertaining to the LHHS and THUD bills
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Affordable Care Act repeal efforts, and specifically their impact on opioid treatment and other health issues; LHHS appropriations and their impact on health issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate Substance Abuse & Mental Health Services Administration (SAMHSA) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
OSHA and NIOSH appropriations; general funding for workplace safety issues
Agencies Lobbied
U.S. Senate U.S. House of Representatives Occupational Safety & Health Administration (OSHA) Centers For Disease Control & Prevention (CDC)
Type of Issue
Labor Issues/Antitrust/Workplace
Lobbying Issues
Funding for NHTSA traffic safety priorities; general support for traffic safety issues; automated vehicle legislation, including S1885 (The American Vision for Safer Transportation Through Advancement of Revolutionary Technologies) and HR3388 (SELF DRIVE Act)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Transportation - Dept of (DOT) Natl Highway Traffic Safety Administration (NHTSA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate